Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06557889 |
| Title | Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas (REDUCE) |
| Acronym | REDUCE |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Institut Claudius Regaud |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Chu Bordeaux - Hopital Saint André | NOT_YET_RECRUITING | Bordeaux | France | Details | ||
| Chu Limoges | NOT_YET_RECRUITING | Limoges | France | Details | ||
| Centre Hospitalier Regional de Marseille | NOT_YET_RECRUITING | Marseille | France | Details | ||
| Centre Antoine Lacassagne | NOT_YET_RECRUITING | Nice | France | Details | ||
| Chu de Nimes | NOT_YET_RECRUITING | Nimes | France | Details | ||
| Clinique Pasteur | NOT_YET_RECRUITING | Toulouse | France | Details | ||
| IUCT-O | RECRUITING | Toulouse | France | Details |